Douglas Galasko

7.3k total citations · 1 hit paper
32 papers, 3.0k citations indexed

About

Douglas Galasko is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Douglas Galasko has authored 32 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 13 papers in Physiology and 12 papers in Psychiatry and Mental health. Recurrent topics in Douglas Galasko's work include Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (11 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Douglas Galasko is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Dementia and Cognitive Impairment Research (11 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Douglas Galasko collaborates with scholars based in United States, Netherlands and China. Douglas Galasko's co-authors include Mary Sano, Steven H. Ferris, David A. Bennett, Michael Grundman, Ronald J. Thomas, Wilmar Dumaop, Paula Desplats, Eliezer Masliah, Leon J. Thal and David P. Salmon and has published in prestigious journals such as Nature, Neurology and Annals of Neurology.

In The Last Decade

Douglas Galasko

28 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease

1997 953 citations Douglas Galasko et al. profile →

Peers

Countries citing papers authored by Douglas Galasko

Since Specialization

Citations

This map shows the geographic impact of Douglas Galasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Galasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Galasko more than expected).

Fields of papers citing papers by Douglas Galasko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Galasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Galasko. The network helps show where Douglas Galasko may publish in the future.

Co-authorship network of co-authors of Douglas Galasko

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Galasko. A scholar is included among the top collaborators of Douglas Galasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Galasko. Douglas Galasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alzheimer's Association Clinical Practice Guideline on the use of blood‐based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings 2025 ·Alzheimer s & Dementia ·Sebastian Palmqvist, Heather E. Whitson, (unknown), Marc Suárez‐Calvet, Douglas Galasko, Thomas K. Karikari, (unknown), (unknown), Suzanne E. Schindler, Charlotte E. Teunissen, Henrik Zetterberg, Marı́a C. Carrillo, Rebecca M. Edelmayer, Simin Mahinrad, (unknown), Lara A Kahale, Sarah Pahlke, Malavika P. Tampi	9
2	Effectiveness and utilization of a cognitive screening program for primary geriatric care 2025 ·Alzheimer s Research & Therapy ·David P. Salmon, (unknown), (unknown), Christina Gigliotti, Emily A. Little, Douglas Galasko	0
3	Overcoming Barriers to Latino Participation in Alzheimer's Disease Research 2024 ·The International Journal of Aging and Human Development ·(unknown), Christina Gigliotti, Emily A. Little, Guerry M. Peavy, (unknown), Alejandra Morlett Paredes, (unknown), Zvinka Z. Zlatar, Diane M. Jacobs, Tamar H. Gollan, Héctor M. González, (unknown), Branko N. Huisa, James B. Brewer, Douglas Galasko, David P. Salmon	0
4	Blood extracellular vesicles carrying synaptic function‐ and brain‐related proteins as potential biomarkers for Alzheimer's disease 2022 ·Alzheimer s & Dementia ·Chen Tian, Tessandra Stewart, Zhen Hong, Zhen Guo, Patrick Aro, (unknown), Catherine Pan, Elaine R. Peskind, Cyrus P. Zabetian, Leslie M. Shaw, Douglas Galasko, Joseph F. Quinn, Min Shi, Jing Zhang, (unknown)	52
5	A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future 2020 ·Alzheimer s Research & Therapy ·Douglas Galasko, Philip Scheltens	3
6	Distinctive patterns of DNA methylation associated with Parkinson disease 2013 ·Epigenetics ·Eliezer Masliah, Wilmar Dumaop, Douglas Galasko, Paula Desplats	246
7	Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression 2010 ·Annals of Neurology ·Min Shi, Joshua M. Bradner, Aneeka M. Hancock, Kathryn A. Chung, Joseph F. Quinn, Elaine R. Peskind, Douglas Galasko, Joseph Jankovic, Cyrus P. Zabetian, Hojoong M. Kim, James B. Leverenz, Thomas J. Montine, Carmen Ginghină, Un Jung Kang, Kevin C. Cain, Yu Wang, Jan Aasly, David Goldstein, Jing Zhang	336
8	Prevalence of dementia in Chamorros on Guam 2007 ·Neurology ·Douglas Galasko, David P. Salmon, Anthony Gamst, John Olichney, L. J. Thal, Lisa C. Silbert, Jeffrey Kaye, Peter Brooks, (unknown), U.-K. Craig, Gerald D. Schellenberg, Amy R. Borenstein	47
9	ALS and PDC of Guam 2002 ·Neurology ·Chris C. Plato, Douglas Galasko, Ralph M. Garruto, (unknown), Anthony Gamst, U.-K. Craig, José Manuel Torres, W. C. Wiederholt	60
10	Extrapyramidal signs and cognitive abilities in Alzheimer's disease 2001 ·International Journal of Geriatric Psychiatry ·Michael P. Caligiuri, Guerry M. Peavy, Douglas Galasko	12
11	Lewy bodies and dementia 2001 ·Current Neurology and Neuroscience Reports ·Douglas Galasko	13
12	Frequency of Tau Gene Mutations in Familial and Sporadic Cases of Non-Alzheimer Dementia 2001 ·Archives of Neurology ·Parvoneh Poorkaj, (unknown), Ellen J. Steinbart, Haydeh Payami, A. Dessa Sadovnick, David Nochlin, Takeshi Tabira, John Q. Trojanowski, Soo Borson, Douglas Galasko, Stephen G. Reich, Bruce Quinn, Gerard D. Schellenberg, Thomas D. Bird	125
13	Part V. Genetic advances and biological markers for alzheimer's disease 2000 ·Disease-a-Month ·Douglas Galasko	0
14	Early‐onset Alzheimer's disease with a presenilin‐1 mutation at the site corresponding to the volga German presenilin‐2 mutation 1997 ·Annals of Neurology ·Richard Crook, Ronald J. Ellis, (unknown), Leon J. Thal, Jordi Pérez‐Tur, Matt Baker, (unknown), Tuomas Haltia, John Hardy, Douglas Galasko	32
15	Clinical and Neuropathological Findings in Lewy Body Dementias 1996 ·Brain and Cognition ·Douglas Galasko, Robert Katzman, David P. Salmon, Laura Hansen	127
16	Genetic-Evidence That the Lewy Body Variant Is Indeed a Phenotypic Variant of Alzheimers-Disease 1995 ·Brain and Cognition ·Robert Katzman, Douglas Galasko, (unknown), L. J. Thal, Laura Hansen	19
17	The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). 1995 ·Neurology ·Douglas Galasko, Steven D. Edland, John C. Morris, Christopher M. Clark, Richard C. Mohs, Elana Koss	84
18	Adjunctive Therapy in Patients with Alzheimerʼs Disease 1995 ·Drugs & Aging ·Jody Corey‐Bloom, Douglas Galasko	16
19	Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide 1993 ·Nature ·Peter Seubert, Tilman Oltersdorf, (unknown), Robin Barbour, C. L. Blomquist, David L. Davis, (unknown), Lawrence C. Fritz, Douglas Galasko, Leon J. Thal, Ivan Lieberburg, Dale B. Schenk	455
20	Lewy body disease. 1992 ·PubMed ·Lawrence A. Hansen, Douglas Galasko	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact